Sarah is the Head of Operations Europe for Legend Biotech and she has over 10 years of experience in cell therapy, biomedical research and development. She is a pharmacist from education and has a PhD in pharmaceutical and biomedical sciences, specialising in stem cell biology. In 2010, she joined Promethera BioSciences, a biopharmaceutical company dedicated to the development of cell therapy products based on allogeneic adult stem cell technology to treat liver diseases. She headed the R&D, QC and Preclinical Departments. In 2015, she joined Celyad, a biopharmaceutical company, that specialises in autologous and allogeneic cell therapy. Celyad’s core business lies in the field of immuno-oncology, and more specifically the development of NK-receptor-based CAR T therapies. Sarah initially led the immune-oncology program at the R&D level, focused on technology transfer, product characterization and optimization.